Immunoprecise(IPA) - 2023 Q2 - Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2023 Earnings Conference Call December 15, 2022 10:30 AM ET Company Participants Jennifer Bath – Chief Executive Officer Barry Duplantis – Vice President-Client Relations Ilse Roodink – Chief Scientific Officer Brad McConn – Chief Financial Officer Conference Call Participants Swayampakula Ramakanth – H.C. Wainwright Michael Freeman – Raymond James Will McHale – Ingalls & Snyder Operator Good morning and thank your standing by. Welcome to ImmunoPrecise Antibody ...